Bo joined Shattuck in April 2019 as Senior Director of Biometrics. She brings over 14 years of oncology clinical development experience spanning from early to late phase in both pharmaceutical and biotechnology companies. Bo has comprehensive experience in oncology early phase clinical development and has been the statistical lead for several oncology compounds. Prior to joining Shattuck, Bo was the Senior Director of Biostatistics in early phase oncology clinical program at Medimmune/AstraZeneca.  Bo started her career as a Clinical Trial Statistician at GlaxoSmithKline (GSK) and spent eight years in oncology clinical development at GSK.  After leaving GSK, Bo spent about three years in a biotech company as the Director of Statistics.  Bo received her PhD in Biostatistics from the University of South Carolina.